Evaluating stocks that led the gains today

Published: September 28 2022, 15:00 GMT+0

Evaluating stocks that led the gains today

Biogen is leading the way, gaining 37.68%

Current market events are being influenced by ambiguous macro data as highly important Crude Oil Inventories data from United States beat analyst expectations of 443,000 with a reading of -215,000.

Biogen | +37.68% at $272.32

The biopharmaceutical company reached a significant high of $287.77 around 11 months ago but has lost 31.27% since then. So far in 2022, it has been outperforming the Nasdaq by 27.21%. Biogen's market cap currently stands at $39.52 billion with an average daily volume of 948,943 shares. Biogen's last revenue report was $2.59 billion with an EPS of $5.25.

Denali Therapeutics | +21.51% at $33.16

Following yesterday's session which closed at $27.29, Denali Therapeutics went up to $33.3 today only to drop back and trade at $33.16.

Biotech Bull and Bear 3X ETF | +9.97% at $7.17

Biotech Bull and Bear 3X ETF is now trading 90.11% below the significant high of $65.93 it set around 10 months ago.

Back